4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0000893838-06-000054
$IRDCIK 0001228627operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 9:06 PM ET
Size
12.1 KB
Accession
0000893838-06-000054
Insider Transaction Report
Form 4
McIntosh David M
Director
Transactions
- Award
Stock option (right to buy)
2005-12-08+125,000→ 125,000 totalExercise: $0.80Exp: 2014-04-20→ Common stock (125,000 underlying) - Award
Stock option (right to buy)
2005-09-12+20,000→ 20,000 totalExercise: $3.00From: 2006-09-12Exp: 2015-09-12→ Common stock (20,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2005-12-08−125,000→ 0 totalExercise: $0.24Exp: 2014-04-20→ Common stock (125,000 underlying) - Award
Stock option (right to buy)
2006-05-01+20,000→ 20,000 totalExercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common stock (20,000 underlying)
Footnotes (2)
- [F1]The options vest and become exercisable as to 30% of the options on April 20, 2005; another 30% of the options on April 20, 2006; and the remaining 40% of the options on April 20, 2007.
- [F2]The transaction involved an amendment of outstanding options to change the exercise price with respect to 125,000 options from $0.24 to $0.80, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 9:06 PM ET
- Size
- 12.1 KB